Published in Pediatr Nephrol on January 21, 2005
Nondiabetic consequences of obesity on kidney. Pediatr Nephrol (2006) 1.07
Nutrition in children with CRF and on dialysis. Pediatr Nephrol (2007) 1.05
Recent advances in obesity: genetics and beyond. ISRN Endocrinol (2012) 0.98
Animal models of anorexia and cachexia. Expert Opin Drug Discov (2009) 0.96
The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res (2007) 0.95
Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney Int (2010) 0.93
Bariatric endocrinology: principles of medical practice. Int J Endocrinol (2014) 0.91
Insulin and its role in chronic kidney disease. Pediatr Nephrol (2007) 0.91
Assessment of nutritional status in children with chronic kidney disease and on dialysis. Pediatr Nephrol (2013) 0.84
Ghrelin in chronic kidney disease. Int J Pept (2010) 0.81
Nutrition assessment and management in children on peritoneal dialysis. Pediatr Nephrol (2008) 0.79
Growth hormone in chronic renal disease. Indian J Endocrinol Metab (2012) 0.78
Uninephrectomy in Rats on a Fixed Food Intake Potentiates Both Anorexia and Circulating Cytokine Subsets in Response to LPS. Front Immunol (2015) 0.76
Understanding cancer-induced cachexia: imaging the flame and its fuel. Curr Opin Support Palliat Care (2011) 0.76
Chronic kidney disease in children. Clin Kidney J (2016) 0.75
Evaluation of Nutritional Biochemical Parameters in Haemodialysis Patients over a Ten-year Period. West Indian Med J (2015) 0.75
Dietary sources of energy and nutrient intake among children and adolescents with chronic kidney disease. Pediatr Nephrol (2017) 0.75
Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 13.05
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science (2000) 5.20
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med (1993) 4.88
Leptin. Annu Rev Physiol (2000) 4.78
Biology of cachexia. J Natl Cancer Inst (1997) 4.18
Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr (1989) 2.75
Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol (1989) 1.99
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J (1989) 1.82
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.77
Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest (1996) 1.67
Role of the central melanocortin system in cachexia. Cancer Res (2001) 1.60
Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur J Clin Invest (2002) 1.54
Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res (1999) 1.45
Leptin and renal disease. Am J Kidney Dis (2002) 1.42
Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med (1994) 1.41
Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol (2002) 1.37
Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis (2000) 1.29
Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int (2002) 1.27
Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis (1995) 1.22
Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J (1974) 1.20
Relation of calorie deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation. N Engl J Med (1971) 1.19
Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int (1990) 1.18
Obesity: keeping hunger at bay. Nature (2002) 1.18
Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest (2002) 1.17
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant (2004) 1.07
Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol Behav (1996) 1.06
Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int (1997) 1.04
Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol (1998) 0.93
Calorie deficiency in children with uremia: effect upon growth. Pediatrics (1972) 0.91
Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol (1998) 0.91
Chemokines/intercrines and central regulation of feeding. Am J Physiol (1994) 0.90
Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int (1988) 0.89
Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant (1997) 0.88
The effects of chronic renal failure in infancy on growth, nutritional status and body composition. Pediatr Res (1982) 0.87
Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant (1998) 0.87
Resting metabolic rate in chronic renal failure. J Ren Nutr (2001) 0.84
Effects of caloric supplementation on growth in children with uremia. Kidney Int (1983) 0.81
Role of dietary energy supplementation in growth of children with chronic renal insufficiency. Br Med J (1977) 0.80
Plasma concentrations of alpha-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis. Nephrol Dial Transplant (2000) 0.80
Leptin, ghrelin, and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease? Adv Ren Replace Ther (2003) 0.80
Immunomodulators and feeding regulation: a humoral link between the immune and nervous systems. Brain Behav Immun (1989) 0.78
Thwarting the dwindling progression of cachexia. Lancet (1998) 0.78
Nitrogen metabolism and growth in experimental uremia. Int J Pediatr Nephrol (1980) 0.75
Body composition in children on regular hemodialysis. Clin Nephrol (1981) 0.75
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron (2003) 6.05
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci (2003) 4.83
Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt (2007) 3.18
Activation of central melanocortin pathways by fenfluramine. Science (2002) 2.71
Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons. Endocrinology (2004) 2.15
Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nat Neurosci (2004) 2.14
Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes (2012) 1.91
Engineered microsphere contrast agents for optical coherence tomography. Opt Lett (2003) 1.91
Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology (2004) 1.80
Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse. Endocrinology (2004) 1.71
Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue. Endocrinology (2006) 1.71
Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease. Nat Clin Pract Endocrinol Metab (2006) 1.70
Optical probes and techniques for molecular contrast enhancement in coherence imaging. J Biomed Opt (2005) 1.67
Compressive holography. Opt Express (2009) 1.66
Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer. Breast Cancer Res Treat (2004) 1.62
The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog Horm Res (2004) 1.60
Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130. Endocrinology (2009) 1.58
Neuropeptide W: an anorectic peptide regulated by leptin and metabolic state. Endocrinology (2010) 1.50
The melanocortin-3 receptor is required for entrainment to meal intake. J Neurosci (2008) 1.49
Characterization of a novel binding partner of the melanocortin-4 receptor: attractin-like protein. Biochem J (2003) 1.49
Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab (2012) 1.46
Creation of a genetic model of obesity in a teleost. FASEB J (2007) 1.35
Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology (2007) 1.34
Three-dimensional optical coherence tomography of the embryonic murine cardiovascular system. J Biomed Opt (2006) 1.33
Stabilization of continuum generation from normally dispersive nonlinear optical fibers for a tunable broad bandwidth source for optical coherence tomography. Opt Lett (2007) 1.32
Inverse scattering for optical coherence tomography. J Opt Soc Am A Opt Image Sci Vis (2006) 1.32
A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology (2003) 1.31
The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides (2005) 1.31
Characterization of leptin-responsive neurons in the caudal brainstem. Endocrinology (2006) 1.30
Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest (2005) 1.30
Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. Cell Metab (2005) 1.29
Projected index computed tomography. Opt Lett (2003) 1.29
Pineal-specific agouti protein regulates teleost background adaptation. Proc Natl Acad Sci U S A (2010) 1.27
Nonparaxial vector-field modeling of optical coherence tomography and interferometric synthetic aperture microscopy. J Opt Soc Am A Opt Image Sci Vis (2007) 1.25
Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology (2007) 1.25
Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology (2007) 1.24
Central serotonin and melanocortin pathways regulating energy homeostasis. Ann N Y Acad Sci (2003) 1.24
Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology (2007) 1.23
Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. Opt Lett (2004) 1.23
Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice. Metabolism (2012) 1.22
Localized waveguide formation in germanosilicate fiber transmitting femtosecond IR pulses. J Opt Soc Am B (2008) 1.22
Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci (2011) 1.22
Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin. Proc Natl Acad Sci U S A (2010) 1.20
Neural control of the anorexia-cachexia syndrome. Am J Physiol Endocrinol Metab (2008) 1.18
Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest (2003) 1.17
Optical biopsy of lymph node morphology using optical coherence tomography. Technol Cancer Res Treat (2005) 1.16
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med (2011) 1.15
Functional optical coherence tomography for detecting neural activity through scattering changes. Opt Lett (2003) 1.15
Design and scaling of monocentric multiscale imagers. Appl Opt (2012) 1.15
The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models. Philos Trans R Soc Lond B Biol Sci (2006) 1.14
High-spectral-resolution coherent anti-Stokes Raman scattering with interferometrically detected broadband chirped pulses. Opt Lett (2006) 1.13
Maternal high fat diet is associated with decreased plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS One (2011) 1.13
Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology (2008) 1.13
Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones. J Hypertens (2006) 1.12
Differential role of melanocortin receptor subtypes in cachexia. Endocrinology (2003) 1.10
Knockout studies defining different roles for melanocortin receptors in energy homeostasis. Ann N Y Acad Sci (2003) 1.10
Molecular histopathology by spectrally reconstructed nonlinear interferometric vibrational imaging. Cancer Res (2010) 1.09
Spatial light interference tomography (SLIT). Opt Express (2011) 1.09
Characterization of the hyperphagic response to dietary fat in the MC4R knockout mouse. Endocrinology (2011) 1.09
Inverse scattering for high-resolution interferometric microscopy. Opt Lett (2006) 1.09
Real-time interferometric synthetic aperture microscopy. Opt Express (2008) 1.08
Study of an ultrahigh-numerical-aperture fiber continuum generation source for optical coherence tomography. Opt Lett (2002) 1.07
Real-time digital signal processing-based optical coherence tomography and Doppler optical coherence tomography. IEEE Trans Biomed Eng (2004) 1.07
Emergence of self-organized long-period fiber gratings in supercontinuum-generating optical fibers. Opt Lett (2009) 1.06
Molecularly sensitive optical coherence tomography. Opt Lett (2005) 1.05
Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun (2005) 1.04
Deconvolution methods for mitigation of transverse blurring in optical coherence tomography. IEEE Trans Image Process (2005) 1.04
Hypothalamic mechanisms in cachexia. Physiol Behav (2010) 1.04
Developmental control of the melanocortin-4 receptor by MRAP2 proteins in zebrafish. Science (2013) 1.03
Metamaterial apertures for coherent computational imaging on the physical layer. J Opt Soc Am A Opt Image Sci Vis (2013) 1.02
Cross-validation of interferometric synthetic aperture microscopy and optical coherence tomography. Opt Lett (2010) 1.02
Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol (2007) 1.02
Needle-based reflection refractometry of scattering samples using coherence-gated detection. Opt Express (2007) 1.00
Agouti-related protein (AGRP) is conserved and regulated by metabolic state in the zebrafish, Danio rerio. Endocrine (2003) 1.00
Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis. Peptides (2005) 0.99
A Postnatal Pax7 Progenitor Gives Rise to Pituitary Adenomas. Genes Cancer (2010) 0.99
Design of a spherical focal surface using close-packed relay optics. Opt Express (2011) 0.99
Conserved neurochemical pathways involved in hypothalamic control of energy homeostasis. J Comp Neurol (2007) 0.99
Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis. J Biol Chem (2011) 0.98
Increased maternal fat consumption during pregnancy alters body composition in neonatal mice. Am J Physiol Endocrinol Metab (2011) 0.98
AgRP and POMC neurons are hypophysiotropic and coordinately regulate multiple endocrine axes in a larval teleost. Cell Metab (2012) 0.98
Melanocortin-3 receptor regulates the normal fasting response. Proc Natl Acad Sci U S A (2012) 0.97
Interferometric Synthetic Aperture Microscopy: Computed Imaging for Scanned Coherent Microscopy. Sensors (Basel) (2008) 0.95
Pathophysiology and treatment of inflammatory anorexia in chronic disease. J Cachexia Sarcopenia Muscle (2010) 0.95
Melanocortin-4 receptor mutations paradoxically reduce preference for palatable foods. Proc Natl Acad Sci U S A (2013) 0.95
RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. J Clin Endocrinol Metab (2015) 0.94
Physiological roles of the melanocortin MC₃ receptor. Eur J Pharmacol (2011) 0.94
Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney Int (2010) 0.93
Melanocortin-5 receptor deficiency promotes defensive behavior in male mice. Horm Behav (2004) 0.93
Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol (2006) 0.93
Autocorrelation artifacts in optical coherence tomography and interferometric synthetic aperture microscopy. Opt Lett (2007) 0.92
The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist. Endocrinology (2005) 0.92
Structural and functional imaging of 3D microfluidic mixers using optical coherence tomography. Proc Natl Acad Sci U S A (2004) 0.91
Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle. FASEB J (2013) 0.91
Regulation of thyrotropin-releasing hormone-expressing neurons in paraventricular nucleus of the hypothalamus by signals of adiposity. Mol Endocrinol (2010) 0.91
Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol (2006) 0.90